Clinicopathological features and prognostic implications of ASCL1 expression in surgically resected small cell lung cancer

BACKGROUND: Small cell lung cancer (SCLC) is one of the most aggressive lung cancers. Treatment of SCLC has remained unchanged during the past decades. Preclinical studies have revealed ASCL1 as a transcription regulator in the neuroendocrine (NE) differentiation and carcinogenesis of SCLC. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jiacong, Liu, Li, Guo, Yiying, Zhang, Jinyao, Wang, Xin, Dong, Jiyan, Xing, Puyuan, Ying, Jianming, Yang, Lin, Li, Junling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779202/
https://www.ncbi.nlm.nih.gov/pubmed/33191657
http://dx.doi.org/10.1111/1759-7714.13705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779202/
https://www.ncbi.nlm.nih.gov/pubmed/33191657
http://dx.doi.org/10.1111/1759-7714.13705

Ejemplares similares